Disc Medicine, Inc. - Common Stock (IRON)

Disc Medicine, Inc. is a biotechnology company focused on developing innovative therapies to address the challenges posed by rare and serious blood disorders

Through rigorous research and advanced drug development, the company aims to create targeted therapies that improve patient outcomes and quality of life. With a strong emphasis on scientific innovation and collaboration, Disc Medicine seeks to harness the latest advancements in medical science to bring transformative treatments from the lab to the clinic, ultimately striving to make a significant impact in the field of hematology.